Sativa Group PLC (LON:SATI) has appointed Clive Page, professor of pharmacology at King's College London, to its medical advisory board.
In a statement, the NEX-listed CBD wellness and medicinal cannabis company noted that Page’s main research interests are in the pharmacology of inflammation and respiratory disease, having published over 300 scientific papers and book chapters, and he is a fellow of the Royal Society of Biology and an honorary fellow of the British Pharmacological Society.
READ: Sativa inks exclusive deal with leading sales and marketing company for CBD range
Nick Horniman, director of regulatory affairs at Sativa commented: “Professor Page is an eminent research scientist and will add to Sativa's experience, interest and understanding in cannabis-based medical products."